Clinical Trial Update: Dalacin-T Gel Post Approval Study [Phase 4]

View source ↗

Summary

Pfizer's post-approval Phase 4 study of Dalacin-T Gel for acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Dalacin-T Gel (clindamycin phosphate topical gel)

Snippet

Sponsor: Pfizer | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED